03/28/2024
12:21 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:19 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024
9:33 AM | ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G | |
02/23/2024
4:26 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
|
02/23/2024
4:29 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024
2:12 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
01/10/2024
12:53 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G/A | |
01/10/2024
12:33 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G | |
12/14/2023
7:48 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
7:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
4:11 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023
3:53 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
12/06/2023
4:19 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023
6:57 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023
5:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
7:31 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
4:13 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:50 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2023
7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2023
7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/20/2023
1:56 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
10:56 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
3:46 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023
1:47 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
7:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/08/2023
7:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023
7:14 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2023
3:38 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
08/09/2023
8:15 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2023
11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
07/14/2023
7:10 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
3:32 PM | ImmunoPrecise Antibodies (Filer)
| Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d) | |
07/07/2023
2:22 PM | ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13D | |
07/07/2023
7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
8:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This is the best new way to score with AI (Ad) If you thought that you missed your chance to score big on AI, I have great news.
A rare second profit window is starting to open. Click now for the best way into the newest AI projects |
06/13/2023
6:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
7:09 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023
7:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2023
10:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
